Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1992
Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytesF Rousset, E Garcia, T Defrance, et al.
European Journal of Immunology|April 1, 1987
The response of selected human B cell lines to B cell growth and differentiation factorsJ G Shields, S H Smith, R J Levinsky, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1986
Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activitiesT Yokota, T Otsuka, T Mosmann, et al.
The Biochemical Journal|December 1, 1994
The vitronectin receptor (alpha v beta 3) is implicated, in cooperation with P-selectin and platelet-activating factor, in the adhesion of monocytes to activated endothelial cellsJ F Murphy, J C Bordet, B Wyler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1988
Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-gammaF Rousset, R W Malefijt, B Slierendregt, et al.
European Journal of Immunology|February 1, 1988
Response of LFA-1-deficient B cells to interleukin 4 (BSF-1) and low molecular weight B cell growth factor (BCGFlow)J G Shields, S H Smith, S Strobel, et al.
The Journal of Experimental Medicine|June 1, 1987
Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytesT Defrance, J P Aubry, F Rousset, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1987
B cell growth-promoting activity of recombinant human interleukin 4T Defrance, B Vanbervliet, J P Aubry, et al.
Blood|July 29, 1998
Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leukemia cellsM F Romano, A Lamberti, P Tassone, et al.
Leukemia|July 31, 2009
The TLR1/2 agonist PAM(3)CSK(4) instructs commitment of human hematopoietic stem cells to a myeloid cell fateK De Luca, V Frances-Duvert, M-J Asensio, et al.
Pageof 6